137 related articles for article (PubMed ID: 18802052)
1. Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo.
Dresch C; Edelmann SL; Marconi P; Brocker T
J Immunol; 2008 Oct; 181(7):4495-506. PubMed ID: 18802052
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.
de Andrade Pereira B; Fraefel C; Hilbe M; Ackermann M; Dresch C
Gene Ther; 2013 May; 20(5):556-66. PubMed ID: 22951454
[TBL] [Abstract][Full Text] [Related]
3. The role of skin-derived dendritic cells in CD8+ T cell priming following immunization with lentivectors.
Furmanov K; Elnekave M; Lehmann D; Clausen BE; Kotton DN; Hovav AH
J Immunol; 2010 May; 184(9):4889-97. PubMed ID: 20357252
[TBL] [Abstract][Full Text] [Related]
4. Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors.
Dullaers M; Van Meirvenne S; Heirman C; Straetman L; Bonehill A; Aerts JL; Thielemans K; Breckpot K
Gene Ther; 2006 Apr; 13(7):630-40. PubMed ID: 16355115
[TBL] [Abstract][Full Text] [Related]
5. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
He Y; Zhang J; Mi Z; Robbins P; Falo LD
J Immunol; 2005 Mar; 174(6):3808-17. PubMed ID: 15749922
[TBL] [Abstract][Full Text] [Related]
6. Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.
Odegard JM; Kelley-Clarke B; Tareen SU; Campbell DJ; Flynn PA; Nicolai CJ; Slough MM; Vin CD; McGowan PJ; Nelson LT; Ter Meulen J; Dubensky TW; Robbins SH
J Immunother; 2015; 38(2):41-53. PubMed ID: 25658613
[TBL] [Abstract][Full Text] [Related]
7. Mucosally delivered dendritic cells activate T cells independently of IL-12 and endogenous APCs.
McCormick S; Santosuosso M; Small CL; Shaler CR; Zhang X; Jeyanathan M; Mu J; Takenaka S; Ngai P; Gauldie J; Wan Y; Xing Z
J Immunol; 2008 Aug; 181(4):2356-67. PubMed ID: 18684925
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
[TBL] [Abstract][Full Text] [Related]
10. Targeting dendritic cells with antigen via dendritic cell-associated promoters.
Moulin V; Morgan ME; Eleveld-Trancikova D; Haanen JB; Wielders E; Looman MW; Janssen RA; Figdor CG; Jansen BJ; Adema GJ
Cancer Gene Ther; 2012 May; 19(5):303-11. PubMed ID: 22361816
[TBL] [Abstract][Full Text] [Related]
11. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
12. Retrovirally transduced mouse dendritic cells require CD4+ T cell help to elicit antitumor immunity: implications for the clinical use of dendritic cells.
Schnell S; Young JW; Houghton AN; Sadelain M
J Immunol; 2000 Feb; 164(3):1243-50. PubMed ID: 10640737
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance.
Werner-Klein M; Dresch C; Marconi P; Brocker T
J Immunol; 2007 Jun; 178(12):7738-46. PubMed ID: 17548611
[TBL] [Abstract][Full Text] [Related]
14. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo.
Kleindienst P; Brocker T
J Immunol; 2003 Mar; 170(6):2817-23. PubMed ID: 12626531
[TBL] [Abstract][Full Text] [Related]
15. miR-155 Upregulation in Dendritic Cells Is Sufficient To Break Tolerance In Vivo by Negatively Regulating SHIP1.
Lind EF; Millar DG; Dissanayake D; Savage JC; Grimshaw NK; Kerr WG; Ohashi PS
J Immunol; 2015 Nov; 195(10):4632-40. PubMed ID: 26447227
[TBL] [Abstract][Full Text] [Related]
16. Peripheral tolerance to a nuclear autoantigen: dendritic cells expressing a nuclear autoantigen lead to persistent anergic state of CD4+ autoreactive T cells after proliferation.
Kawahata K; Misaki Y; Yamauchi M; Tsunekawa S; Setoguchi K; Miyazaki J; Yamamoto K
J Immunol; 2002 Feb; 168(3):1103-12. PubMed ID: 11801644
[TBL] [Abstract][Full Text] [Related]
17. Induction of immune tolerance to FIX by intramuscular AAV gene transfer is independent of the activation status of dendritic cells.
Bharadwaj AS; Kelly M; Kim D; Chao H
Blood; 2010 Jan; 115(3):500-9. PubMed ID: 19965663
[TBL] [Abstract][Full Text] [Related]
18. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
19. Engineered lentivector targeting of dendritic cells for in vivo immunization.
Yang L; Yang H; Rideout K; Cho T; Joo KI; Ziegler L; Elliot A; Walls A; Yu D; Baltimore D; Wang P
Nat Biotechnol; 2008 Mar; 26(3):326-34. PubMed ID: 18297056
[TBL] [Abstract][Full Text] [Related]
20. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C
J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
